Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
SiteOne subsidiary Devil Mountain acquires Patterson Nursery Sales

SiteOne subsidiary Devil Mountain acquires Patterson Nursery Sales

ReutersReuters2026/08/04 20:25
  • SiteOne’s Devil Mountain Wholesale Nursery acquired Patterson Nursery Sales, an Oregon grower and distributor of premium nursery products.
  • The deal expands Devil Mountain’s footprint in the Pacific Northwest, supporting a broader push to scale nursery distribution across the US.
  • Patterson supplies customers nationwide, strengthening Devil Mountain’s ability to ship nursery products coast-to-coast.
  • The transaction marks SiteOne’s third acquisition in 2026, its first this year through Devil Mountain.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SiteOne Landscape Supply Inc. published the original content used to generate this news brief on August 04, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

GE HealthCare (GEHC.US) plans to acquire Sofie for $1 billion, aiming for high growth in the radiopharmaceutical sector

GE Healthcare plans to acquire Sofie for about $1 billion, aiming to expand recurring revenue by combining imaging devices with radiodiagnostic agents, in response to weak stock performance and pressure from activist investors.

智通财经2026/09/14 02:36
GE HealthCare (GEHC.US) plans to acquire Sofie for $1 billion, aiming for high growth in the radiopharmaceutical sector